Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is Pfizer's 6.9%-Yielding Dividend Still Safe?


Healthcare giant (NYSE: PFE) has been offering a high yield for some time. But that hasn't been enough to get investors to buy up the stock. You can see that in its sluggish share price, and also in the fact that the dividend still yields an incredibly high amount at 6.9%. That's nearly six times the S 500 average of 1.2%.

Investors are clearly having doubts about the dividend, and perhaps the company as well. If they weren't, then clearly it would be a steal of a deal, the stock would take off, and the yield would come down. If investors aren't touching a stock, there's usually some nagging concern about it.

Below, I'll look at whether Pfizer's dividend is safe and whether it could be a reliable income stock to own right now.

Continue reading


Source Fool.com

Pfizer Inc. Aktie

23,18 €
-0,26 %
Ein geringer Verlust bei Pfizer Inc. heute, um -0,26 %.
Leichte Buy-Präferenz bei der Pfizer Inc. Aktie.
Ein positives, wenn auch nicht starkes, Potenzial für Pfizer Inc. mit einem Kursziel von 27 € im Vergleich zu 23.18 €.
Like: 0
PFE
Teilen

Kommentare